Coherus Oncology, Inc. (CHRS)
NGM – Real Time Price. Currency in USD
1.23
+0.01 (1.24%)
Market open: Aug 12, 2026, 10:08 AM EDT
1.21
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
1.23
+0.01 (1.24%)
Market open: Aug 12, 2026, 10:08 AM EDT
1.21
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $82.9M significantly exceed its total debt $54.2M, ensuring strong financial flexibility
Total current assets $133.8M exceed Total current liabilities $75.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.9) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-13.9x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$62.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.77 | 6.05 | 9.0 | |
| Quick ratio | 1.70 | 5.63 | 8.0 | |
| Debt to Equity | 0.89 | 0.30 | 6.0 | |
| Debt to Assets | 0.28 | 1.04 | 7.0 | |
| Interest coverage | -13.92 | -16.91 | 1.0 | |
| Weighted average score | 6.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 211M | 257M | 26M | 42M | 51M |
| Gross Profit | 137M | 94M | 12M | 24M | 32M |
| Operating Income | -257M | -193M | -193M | -180M | -157M |
| Net Income | -292M | -238M | -148M | -170M | -131M |
| EBITDA | -253M | -189M | -188M | -176M | -153M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 38.38 | 30.32 | 10 |
| Next quarter | 42.74 | 44.44 | 10 |
| Current year | 43.74 | 40.77 | 10 |
| Next year | 45.38 | 33.62 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 16.22 | 46.44 | 18.52 | -7.25 | 7.3 |
| Y/Y | 39.53 | 50.84 | 43.59 | -33.14 | 7.8 |
| 3y average | -2.67 | 13.74 | -193.79 | -153.78 | 2.8 |
| 5y average | -14.94 | -55.49 | -183.04 | -223.13 | 1.0 |
| Weighted average score | 4.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |